Introduction
In this article I will review: (1) the interrelationships between various calciotropic hormones; (2) the mechanism of action of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ); (3) the structure and distribution of the vitamin D receptor in various tissues; (4) the regulation of vitamin D receptor levels in various tissues in normal situations; and (5) the regulation of the vitamin D receptor in uraemia.
The physiology of calciotropic hormones
Briefly, in hypocalcaemic situations, both PTH and 1,25(OH) 2 D 3 play important roles in normalizing serum calcium concentrations [1] [2] [3] . A decrement in serum calcium is sensed via calcium receptors and causes the release of preformed PTH [4] [5] [6] . PTH increases the mobilization of soft tissue calcium and phosphorus and also increases the reabsorption of calcium in the nephron. In addition, PTH increases
Correspondence and offprint requests to: R. Kumar The mechanism of action of 1,25(OH) 2 D 3 1,25(OH) 2 D 3 acts in various tissues by both nuclear (genomic) and membrane-associated (non-genomic) mechanisms [7, 8] . Genomic events occur after the hormone associates with its intracellular receptor, the 1,25(OH) 2 D 3 receptor, and non-genomic events occur as a result of direct effects on membrane channels of proteins [7, 8] . A bulk of the activities of 1,25(OH) 2 
Cellular distribution of the vitamin D receptor
The vitamin D receptor is widely distributed in many epithelial tissues, such as the absorptive cells of the intestine, the proximal and distal tubular cells of the kidney, and in epithelial cells of the reproductive organs [37, 38, 40] . The receptor is also present in various endocrine cells such as those of the pituitary gland, the pancreas, and parathyroid glands [37, 41] . The receptor is also present in bone cells, particularly osteoblast-like cells. Table 3 , adaptation to a low calcium diet, a manoeuvre that is known to increase the synthesis of 1,25(OH) 2 D 3 does not result in an increase in the amount of the vitamin D receptor in the duodenum or the kidney (in fact there may be a decrease in vitamin D receptor concentrations in the kidney following adaptation to a low calcium diet). This has been confirmed by Christakos and her colleagues who In bone cells, 1,25(OH) 2 D 3 appears to increase vitamin D receptor mRNA levels. PTH at a dose of 1 nM and 10 nM also increases vitamin D receptor mRNA concentrations in bone cells [68] .
The structure of the vitamin D receptor
The effect of 1,25(OH) 2 D 3 on vitamin D receptors has also been examined in yeast cells. Here, the addition of 1,25(OH) 2 D 3 results in a 5-fold increase in the amount of the 1,25(OH) 2 D 3 receptor 6 and 8 h after the administration of ligand [70] .
In fibroblast-like cells maintained in culture the addition of 1,25(OH) 2 D 3 at a concentration of 10 nM results in an increase in the amount of vitamin D receptor protein in these cells approximately 2-4 h after the administration of ligand [71] . On the other hand, mRNA concentrations are not substantially increased in these cells, suggesting that the ligand has a predominant effect on the stabilization of pre-existing vitamin D receptor protein as opposed to an increase in the synthesis of new protein via an increase in synthesis of mRNA.
In the parathyroid glands, 1,25(OH) 2 D 3 causes a suppression of PTH pre-pro-mRNA content [64] [65] [66] . This is associated with a decrease in the secretion rate of PTH and the effect appears to be reversible. The 
Vitamin D receptor in uraemia
Several investigators have examined basal concentrations of vitamin D receptor in parathyroid glands of uraemic animals and humans [72, 73] . Basal levels of vitamin D receptors are reduced in these glands in the presence of uraemia. Basal levels of the vitamin D receptor in the intestine of uraemic animals are not altered. Korkor examined the amount of vitamin D receptor present in the parathyroid glands of patients with chronic renal failure, post-kidney transplantation, and in primary hyperparathyroidism [72] . The amount of receptor present in the glands of patients with chronic renal failure was substantially less than that in other states. These results have been confirmed by studies in uraemic animals [73] . Koyama In addition to observations concerning the amount of receptor present in various tissues, Patel and others have shown that uraemic ultrafiltrates contain a factor that inhibits the interaction of vitamin D receptors with DNA cellulose [75, 76] . They have also shown that vitamin D receptor extracted from rats with renal failure shows impaired binding to a vitamin D regulatory element [77] . They have shown that this effect is recapitulated by the incubation of normal vitamin D receptor with an uraemic plasma ultrafiltrate. 
